FDA
-
-
-
-
-
-
-
ZyVersa Therapeutics (ZVSA) CEO Issues Shareholder Letter on PARASOL Recommendations
-
-
-
-
-
-
-
ZyVersa Therapeutics Adds Dr. Richard J. Glassock to Its Renal Scientific Advisory Board to Support Clinical Advancement of Renal Cholesterol Efflux Mediator™ VAR 200
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

